Amsterdam Neuroprosthetics Startup Phosphoenix Secures €1.3M to Advance Blindness Treatment
Amsterdam‑based MedTech startup Phosphoenix secured €1.3 million to advance its brain‑implant neuroprosthesis aimed at restoring functional vision for people with profound blindness, moving toward a first‑in‑human trial and a future Series A round.